Ferric Patents (Class 424/647)
  • Patent number: 11111261
    Abstract: The present invention relates to iron complex compounds for therapeutic use which are low in arsenic, chromium, lead, cadmium, mercury and/or aluminum, compositions thereof and processes for preparing said iron complex compounds.
    Type: Grant
    Filed: February 13, 2019
    Date of Patent: September 7, 2021
    Assignee: Pharmacosmos Holding A/S
    Inventors: Tobias S. Christensen, Hans B. Andreasen
  • Patent number: 10908067
    Abstract: A method for evaluation of deleterious phase content and distribution in stainless steels and nickel-based alloys based on the correlation between measured open circuit potentials and volume fraction of deleterious phases is disclosed, in conjunction with a portable equipment and apparatus for carrying out the method.
    Type: Grant
    Filed: March 1, 2017
    Date of Patent: February 2, 2021
    Assignee: VETCO GRAY SCANDINAVIA AS
    Inventors: Mariano Iannuzzi, Atle Helge Qvale, Alexander Fjeldly
  • Patent number: 10342822
    Abstract: A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: July 9, 2019
    Assignees: Board of Regents of the University of Texas System, Neogenis Labs, Inc.
    Inventors: Nathan S. Bryan, Jose G. Rocca
  • Patent number: 9913806
    Abstract: Embodiments of the invention provide patches for the transdermal delivery of iron-containing compositions to an individual suffering from an iron deficiency. Many embodiments provide an iontophoretic patch for the transdermal delivery of a therapeutically effective amount of iron. The patch comprises an electrode and a reservoir containing a composition comprising ionic iron for the delivery of the therapeutically effective amount of iron. Various embodiments provide methods of using embodiments of the iontophoretic patch for delivering a therapeutically effective amount of iron to an individual suffering from one more forms of iron deficiency including iron deficiency anemia. Such methods can be used for treating and/or preventing the iron deficiency. The amount of delivered iron can be adjusted depending upon various treatment parameters such as patient weight and type and amount of iron deficiency.
    Type: Grant
    Filed: June 25, 2009
    Date of Patent: March 13, 2018
    Assignee: FE3 MEDICAL, INC.
    Inventor: Ronald J. Berenson
  • Patent number: 9763868
    Abstract: A problem of the present invention is to provide a skin collagen production-promoting agent without safety problems. Another problem of the present invention is to provide a skin collagen production-promoting food or drink product and a skin collagen production-promoting cosmetic product containing such a substance. TGF-? and/or a TGF-? degradation product, which is acquired by degrading TGF-? with a protease such as pepsin, pancreatin, etc., are used as a skin collagen production-promoting agent or the active ingredient of a skin collagen production-promoting food or drink product and a skin collagen production-promoting cosmetic product. The aforementioned TGF-? and/or TGF-? degradation product have an effect of increasing the collagen content of the skin.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: September 19, 2017
    Assignee: MEGMILK SNOW BRAND CO., LTD.
    Inventors: Hiroshi Ueno, Yoshikazu Morita, Aiko Ono, Ken Katoh, Noriko Ueda
  • Patent number: 9168270
    Abstract: There is provided a granular material comprising (i) at least 50% by weight based on the weight of the granular material of solid water-insoluble mixed metal compound capable of binding phosphate of formula (I): MII1-xMIIIx(OH)2An-y.ZH2O (I) where MII is at least one of magnesium, calcium, lanthanum and cerium; MIII is at least iron(III); An- is at least one n-valent anion; x=?ny; 0<x?0.67, 0<y?1, and 0?z<10; (ii) from 3 to 12% by weight based on the weight of the granular material of non-chemically bound water, and (iii) no greater than 47% by weight based on the weight of the granular material of excipient.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: October 27, 2015
    Assignee: OPKO IRELAND GLOBAL HOLDINGS, LTD.
    Inventors: Ruth Diane Pennel, Maurice Sydney Newton, James David Morrison, Alexis John Toft, Nigel Peter Rhodes
  • Publication number: 20150132407
    Abstract: There is provided a granular material comprising (i) at least 50% by weight based on the weight of the granular material of solid water-insoluble mixed metal compound capable of binding phosphate of formula (I): MII1-x.MIIIx(OH)2An?y.zH2O (I) where MII is at least one of magnesium, calcium, lanthanum and cerium; MII is at least iron(III); A is at least one n-valent anion; x=?ny, 0<x?0.67, 0<y?1, and 0?z<10; (ii) from 3 to 12% by weight based on the weight of the granular material of non-chemically bound water, and (iii) no greater than 47% by weight based on the weight of the granular material of excipient.
    Type: Application
    Filed: January 22, 2015
    Publication date: May 14, 2015
    Inventors: Ruth Diane Pennel, Maurice Sydney Newton, James David Morrison, Alexis John Toft, Nigel Peter Rhodes
  • Publication number: 20150132406
    Abstract: A method of selecting or determining a candidate compound suitable for use as a phosphate binder is disclosed. The candidate compound includes ferric compounds, ferric compound complexes, and their derivatives, salts, analogs, and metabolites. The effectiveness of the candidate compound as a phosphate binder is evaluated by a method, comprising measuring and correlating reduction of phosphate concentration in solution and reduction of phosphate absorption in cells.
    Type: Application
    Filed: January 12, 2015
    Publication date: May 14, 2015
    Inventor: Keith Chan
  • Patent number: 9005638
    Abstract: This invention provides cosmetics containing a multi-functional composite powder having the properties of (a) an excellent adhesiveness, (b) an excellent extendability, (c) an appropriate glossy effect, (d) a homogeneous cosmetic film, (e) an appropriate covering capability, (f) a cosmetic film not causing a white masking, (g) a high compatibility between a color appearance of cosmetics and a color tone of the cosmetic film, (h) an excellent soft-focusing capability, (i) an excellent ultraviolet protective effect, and the like. The multi-functional composite powder is constituted by a scale-like base material, a group of particles comprising at least fine particles of titanium dioxide deposited on a surface of the scale-like base material, and a thin film of a composite oxide containing titanium and iron coated thereon.
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: April 14, 2015
    Assignee: JGC Catalysts and Chemicals Ltd.
    Inventors: Shuji Matsumoto, Naoyuki Enomoto, Yasutaka Miyoshi, Takumi Miyazaki
  • Patent number: 8986741
    Abstract: A sunscreen composition for application for plants comprises Titanium Dioxide (TiO2), Zinc Oxide (ZnO), Silicon Dioxide (SiO2), a surfactant, wetting agent, dispersant (SWD) and water. The composition forms a suspension concentrate when combined that when diluted in water provides a solution that provides uniform coverage using convention spraying equipment. A method of protecting plants including turfgrass from ultraviolet radiation, heat stress and/or sunburn comprises combining TiO2, ZnO, SiO2, SWD and water to form a suspension concentrate. The suspension concentrate is then diluted in water and applied to an area in which sun protection is desired.
    Type: Grant
    Filed: October 15, 2013
    Date of Patent: March 24, 2015
    Inventor: Scott May
  • Patent number: 8979726
    Abstract: A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound.
    Type: Grant
    Filed: February 6, 2013
    Date of Patent: March 17, 2015
    Assignee: Biolife, L.L.C.
    Inventors: John Hen, Talmadge Kelly Keene, Mark Travi
  • Patent number: 8974854
    Abstract: A composition for treating cellulosic materials is provided. The composition comprises a dispersion of micronized additives. The dispersion comprises additive particles with diameters in the range of 0.001 to 25 microns. Also provided is a method for the application of the additive-containing composition to wood, as well as wood products which have been treated with the composition.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: March 10, 2015
    Assignee: Koppers Performance Chemicals Inc.
    Inventors: Robert M. Leach, Jun Zhang
  • Patent number: 8968699
    Abstract: The invention provides nanodevices or products of manufacture for use as drug delivery vehicles. In one aspect, the invention provides nanodevices or products of manufacture having on-off release mechanisms, e.g., that are “switchable”, or “actuatable” (for example magnetically or ultrasonically switchable), for compounds contained within, e.g., for use as drug delivery nano-vehicles having on-off drug release mechanisms, and their therapeutic applications.
    Type: Grant
    Filed: November 14, 2008
    Date of Patent: March 3, 2015
    Assignee: The Regents of the University of California
    Inventors: Sungho Jin, Seunghan Oh, Karla Brammer, Seong Kong
  • Patent number: 8932648
    Abstract: A method of selecting or determining a candidate compound suitable for use as a phosphate binder is disclosed. The candidate compound includes ferric compounds, ferric compound complexes, and their derivatives, salts, analogs, and metabolites. The effectiveness of the candidate compound as a phosphate binder is evaluated by a method, comprising measuring and correlating reduction of phosphate concentration in solution and reduction of phosphate absorption in cells.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: January 13, 2015
    Assignee: Globoasia, LLC
    Inventor: Keith Chan
  • Publication number: 20140356429
    Abstract: The present invention provides a new preparation which is a tablet containing (1) ferric citrate, (2) a polyvinyl alcohol-polyethylene glycol graft copolymer, and (3) a polyvinyl alcohol-acrylic acid-methyl methacrylate copolymer
    Type: Application
    Filed: January 2, 2014
    Publication date: December 4, 2014
    Applicant: JAPAN TOBACCO INC.
    Inventors: Masayoshi Fukushima, Kazuhiro Orita, Shogo Yamane
  • Publication number: 20140348825
    Abstract: The present invention provides methods and compositions for the remote control of cell function based on the use of radiofrequency waves to excite nanoparticles targeted to specific cell types. The nanoparticles may be applied to the target cell extracellularly and/or expressed intracellularly. The cell type of interest expresses a temperature sensitive channel wherein excitation of the nanoparticles results in a localized temperature increase that is transduced into a cellular response. Such cellular responses may include, for example, increases in gene expression resulting in production of one or more physiologically active proteins. The expression of such proteins can be used to treat a variety of different inherited or acquired diseases or disorders in a subject. Accordingly, the invention provides a generic approach for treatment of any disease associated with a protein deficiency.
    Type: Application
    Filed: August 24, 2012
    Publication date: November 27, 2014
    Applicant: THE ROCKEFELLER UNIVERSITY
    Inventors: Jeffrey Friedman, Sarah Stanley
  • Publication number: 20140335202
    Abstract: The present invention relates to a process for the preparation of a novel composition, and to the use of the composition as a phosphate adsorbent, in particular for administration in humans or animals.
    Type: Application
    Filed: July 23, 2014
    Publication date: November 13, 2014
    Inventors: Hans-Martin Müller, Erik Philipp, Peter Geisser
  • Publication number: 20140316491
    Abstract: The present invention provides compositions and methods for decreasing photosensitivity induced by photodynamic therapy (PDT). The compositions and methods of the present method employ porphyrin complexing molecules as agents for reducing photosensitivity.
    Type: Application
    Filed: November 25, 2013
    Publication date: October 23, 2014
    Applicant: DUSA Pharmaceuticals, Inc.
    Inventors: Scott Lundahl, Stuart Marcus
  • Patent number: 8846765
    Abstract: A pharmaceutical combination comprising as components (a) at least one 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol compound, and (b) at least one NMDA-antagonist, a pharmaceutical formulation and a dosage form comprising such a combination, and a method of treating pain, e.g. inflammatory pain or neuropathic pain, in which components (a) and (b) are administered simultaneously or sequentially to a mammal, with component (a) being administered either before or after component (b), and with components (a) or (b) being administered to the mammal either via the same pathway of administration or via different pathways of administration.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: September 30, 2014
    Assignee: Gruenenthal GmbH
    Inventors: Klaus Schiene, Petra Bloms-Funke
  • Patent number: 8840931
    Abstract: The present invention provides a pharmaceutical composition for dehydrating, atrophying and eliminating pathological tissues comprising inorganic polymeric ferric salt and/or inorganic polymeric ferric salt composite as its active ingredients, in which the inorganic polymeric ferric salt is polyferric sulfate, and the inorganic polymeric ferric salt composite is selected from a group consisting of poly-silicate ferric salts, polyphosphate ferric salts and their analogue. A surprising medical effect can be reached by treating pathological tissues with the pharmaceutical composition of the present invention which will make the treated pathological tissues dehydrated, atrophied, and absorbed or sloughed off.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: September 23, 2014
    Inventors: Kuok Leong Tam, Io cheng Tam, Hio man Tam
  • Publication number: 20140248363
    Abstract: The present invention relates to a phosphate adsorbent on the basis of maghemite or maghemite/magnetite comprising (i) an iron oxide core comprising a crystal structure of inverse spinel iron oxide, (ii) a coating selected from monomeric carbohydrates, in particular monosaccharides or disaccharides, alditols, or mixtures thereof, and/or (iii) a pharmaceutical excipient selected from polymeric carbohydrates, wherein the phosphate adsorbent has the form of nanoparticles with a particle size of the iron oxide core (i) of less than 20 nm. The present invention further relates to a method for the production of a phosphate adsorbent on the basis of maghemite or maghemite/magnetite, to pharmaceutical compositions comprising the phosphate adsorbent, and to medical uses thereof, especially for the prevention and/or treatment of hyperphosphatemia.
    Type: Application
    Filed: March 7, 2014
    Publication date: September 4, 2014
    Inventors: Susanne WAGNER, Matthias TAUPITZ, Eyk SCHELLENBERGER, Jorg SCHNORR, Monika EBERT, Gesche GENTER, Harald KRATZ
  • Publication number: 20140249351
    Abstract: A microparticle composition(s) comprising nanomagnetic particles and a matrix, wherein said microparticle composition(s) have a least one of the following properties: (a) a VAR of at least about 1 Watts/cm3 subject to appropriate field conditions; (b) a density of about 2.7 or less: or (c) a size of about 100 nm to about 200 microns.
    Type: Application
    Filed: May 15, 2014
    Publication date: September 4, 2014
    Applicant: Sirtex Medical Limited
    Inventors: Stephen Keith Jones, Katrina Francis Rutherford, Andrew John Ruys, Bruce Nathaniel Gray
  • Publication number: 20140242187
    Abstract: Compositions comprising ferrous and/or ferric iron compounds and fiber in a complex, methods for preparing such compositions of matter, and the use thereof for treatment of adsorbing certain accessible targets in the gastrointestinal tract and in an extracorporeal system, are provided herein.
    Type: Application
    Filed: October 12, 2012
    Publication date: August 28, 2014
    Inventor: Jinshyun Ruth Wu-Wong
  • Patent number: 8815301
    Abstract: The invention relates to an iron oligosaccharide compound with improved stability comprising a hydrogenated oligosaccharide in stable association with ferric oxyhydroxide, the content of dimer saccharide in said hydrogenated oligosaccharide being 2.9% by weight or less, based on the total weight of the hydrogenated oligosaccharide. In further aspects is provided a process for preparing said compound as well as the use of said compound for preparation of a composition for treatment of iron deficiency anaemia.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: August 26, 2014
    Assignee: Pharmacosmos Holding A/S
    Inventor: Hans Andreasen
  • Publication number: 20140205667
    Abstract: There is provided a method of producing a mixed metal compound comprising at least Mg2+ and at least Fe3 + having an aluminium content of less than 10000 ppm, having an average crystal size of less than 20 nm (200 A) comprising the steps of: (a) combining a Mg2+ salt and a Fe3 + salt with Na2CO3 and NaOH to produce a slurry, wherein the pH of the slurry is maintained at from 9 5 to 1 1, and wherein the Na2CO3 is provided at an excess of 0 to 4.0 moles than is required to complete the reaction (b) subjecting the slurry to mixing under conditions providing a power per unit volume of 0 03 to 1.6 kW/m3 (c) separating the mixed metal compound from the slurry, to obtain a crude product having a dry solid content of at least 10 wt % (d) drying the crude product either by (i) heating the crude product to a temperature of no greater than 150° C. and sufficient to provide a water evaporation rate of 0.
    Type: Application
    Filed: March 24, 2014
    Publication date: July 24, 2014
    Applicant: CYTOCHROMA DEVELOPMENT INC.
    Inventors: Richard Jonathan Applewhite, James David Morrison, Maurice Sydney Newton, Nigel Peter Rhodes, Christopher John Rickard
  • Patent number: 8785379
    Abstract: Pest controlling compositions exhibiting enhanced pesticidal activity levels are disclosed. In one embodiment, a composition includes at least one pesticide, at least one transition metal salt and at least one proteinaceous material. In this embodiment, the composition exhibits enhanced pesticidal activity levels compared to a composition dissimilar only in not having the at least one transition metal salt and the at least one proteinaceous material.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: July 22, 2014
    Assignee: Dow AgroSciences, LLC.
    Inventors: Stephen L. Wilson, Lei Liu, James D. Thomas, Raymond E. Boucher, Jr., James E. Dripps, Margaret S. Kempe
  • Publication number: 20140178310
    Abstract: Iron oxide complexes, pharmacological compositions and unit dosage thereof, and methods for their administration, of the type employing an iron oxide complex with a polyol, are disclosed. The pharmacological compositions employ a polysaccharide iron oxide complex, wherein the polysaccharide is a modified polyol such as a carboxyalkylated reduced dextran. The complex is stable to terminal sterilization by autoclaving. The compositions are suitable for parenteral administration to a subject for the treatment of iron deficiencies or as MRI contrast agent. The complex is substantially immunosilent, provide minimal anaphylaxis and undergo minimal dissolution in vivo. The pharmacological compositions of the complex contain minimal free iron which can be quantified by a variety of methods.
    Type: Application
    Filed: July 9, 2013
    Publication date: June 26, 2014
    Inventors: Ernest V. Groman, Kenneth G. Paul, Timothy B. Frigo, Howard Bengele, Jerome M. Lewis
  • Patent number: 8722101
    Abstract: The present invention relates to novel therapeutic uses of iron(III) complex compounds with carbohydrates or derivatives thereof, in the preparation of a medicament for improving immune defence and/or brain performance.
    Type: Grant
    Filed: January 18, 2006
    Date of Patent: May 13, 2014
    Assignee: Vifor (International) AG
    Inventors: Jessica Tanner-Baumgartner, Ranjeet Chandra, Peter Geisser
  • Publication number: 20140120169
    Abstract: A process for preparing polymeric composite particles includes the steps of preparing an oil phase containing a biodegradable polymer and a water phase containing a hydrophilic compound or nanoparticle and emulsifying the oil phase in the water phase to form emulsions. Then solvent is removed from the emulsions to prepare the particles in the form of capsules and spheres in sizes from 0.01 ?m (10 nm) to 50 ?m.
    Type: Application
    Filed: October 24, 2013
    Publication date: May 1, 2014
    Applicant: Board of Trustees of Michigan State University
    Inventors: Ilsoon Lee, Shaowen Ji
  • Patent number: 8709396
    Abstract: The invention is a method for attracting mosquitoes by producing a volatilized acid by combining an acid precursor with water to produce the humidified vapor acid attractant, preferably hydrogen chloride. The humidified volatilized acid can be further combined with carbon dioxide, or carbon dioxide can be simultaneously produced to attract mosquitoes. The acid precursor can be a hydrate of ferric chloride, such as ferric chloride hexahydrate. The acid precursor can be impregnated in a carrier, and can be combined with water through exposure to water vapor in the atmosphere, the intentional addition of water, or water produced by a chemical reaction.
    Type: Grant
    Filed: February 18, 2008
    Date of Patent: April 29, 2014
    Assignee: Premark FEG L.L.C.
    Inventors: Joel Tenney, Tom Isaac, William Ernst
  • Patent number: 8658193
    Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: February 25, 2014
    Inventor: Robert J. Greenwald
  • Publication number: 20140030355
    Abstract: The invention provides a mineral complex comprising about 40 wt. % to about 60 wt. % SiO2, about 6 wt. % to about 16 wt. % Fe2O3, about 4 wt. % to about 12 wt. %. CaO, and about 2 wt. % to about 8 wt. % MgO. The invention also provides animal feeds comprising the mineral complex. Methods for increasing the feed efficiency and weight gain in an animal by administering the mineral complex or an animal feed comprising the mineral complex also are provided.
    Type: Application
    Filed: August 15, 2013
    Publication date: January 30, 2014
    Inventor: Justin Cannock
  • Publication number: 20130330416
    Abstract: Technologies are described herein for styptic compounds comprising a hemostatic or styptic agent suspended within a hydrophobic carrier medium. Example carrier mediums may include waxes, lipids, oils, or combinations thereof. The compound may be a semisolid at room temperature and soft enough to be easily dispensed and formed into or onto bleeding tissue of an animal or human. The hydrophobic qualities of the carrier medium can protect the styptic agent from absorbing moisture. The carrier medium can mechanically support positioning treatments adjacent to the bleeding tissue. The carrier medium can further serve to mechanically seal the tissue to aid in hemostasis while also protecting the tissue from debris and contamination. The carrier medium can aid in maintaining moisture within the tissue. Slurry-based manufacturing processes can support a substantially homogeneous dispersal of styptic agent throughout the carrier medium.
    Type: Application
    Filed: June 8, 2012
    Publication date: December 12, 2013
    Inventor: Robert J. Greenwald
  • Patent number: 8603576
    Abstract: A composition for treating cellulosic materials is provided. The composition comprises a dispersion of micronized additives. The dispersion comprises additive particles with diameters in the range of 0.001 to 25 microns. Also provided is a method for the application of the additive-containing composition to wood, as well as wood products which have been treated with the composition.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: December 10, 2013
    Assignee: Osmose, Inc.
    Inventors: Robert M. Leach, Jun Zhang
  • Patent number: 8597419
    Abstract: Disclosed are compositions and processes for the preservation of porous materials, particularly porous fibrous materials, such as wood, wood composites, other processed wood materials, paper, board, card, textiles, rope, cordage and leather. Also for horticultural and agricultural application to plants or growing media prevent the growth and spread of fungal and other disease. The compositions contain salts of one or more preservative metals and carboxylic acids having one or a plurality of hydroxyl groups rendered soluble by means of complex formation with boric acid or a water soluble salt thereof. Application of the compositions of this invention to the porous organic material may be by any means used with conventional preservative solutions, for example soaking, spraying, brushing and vacuum or pressure application or other contact of the solution with the material to be treated.
    Type: Grant
    Filed: January 17, 2008
    Date of Patent: December 3, 2013
    Assignee: Genics Inc.
    Inventor: John A. Betts
  • Publication number: 20130316018
    Abstract: The present invention relates to a new manufacture process for producing an iron containing phosphate adsorbent, in particular to a process for manufacturing and isolating an iron(III)-based phosphate adsorbent which exhibits valuable pharmacological properties.
    Type: Application
    Filed: July 31, 2013
    Publication date: November 28, 2013
    Applicant: Novartis AG
    Inventors: Daniel Kaufmann, Nicole Bieri, Ulrich Meier, Ranjit Thakur, Zdenek Zencak, Christa Hartmann, Andreas Meyer
  • Publication number: 20130309380
    Abstract: Methods of preserving fresh produce with a produce preservative which extends the shelf life of fresh produce, particularly cut fresh produce, and preserves the texture, flavor, appearance, crispness, and color of the fresh produce, particularly the exposed surface of the fresh produce, are provided. The method comprises: providing a solution of produce preservative comprising: water; a preservative cation which is selected from the group consisting of a strontium ion, lithium ion, barium ion, aluminum ion, copper ion, ammonium ion, iron ion, manganese ion, potassium ion, or mixtures thereof; and ascorbate ions, or erythorbate ions; wherein the ascorbate ions or erythorbate ions and the preservative cation are present in an ion ratio of preferably from 0.2:1 to 8:1, more preferably 0.75:1 to 8:1, even more preferably from 1:1 to 4:1, yet more preferably 1.5:1 to 3:1; most preferably 1.1:1 to 2.5:1; and, applying said produce preservative to the produce.
    Type: Application
    Filed: July 26, 2013
    Publication date: November 21, 2013
    Applicant: NatureSeal, Inc.
    Inventors: Chao Chen, Xiaoling Dong, Kenneth James
  • Patent number: 8568759
    Abstract: The present invention provides an environmentally compatible, pesticidal composition and method for the control of insect pests. The composition includes two components. The first component is a chelating agent, a metal complex of a chelating agent, and mixtures thereof, and the second component is preferably a carrier material.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: October 29, 2013
    Assignee: W. Neudorff GmbH KG
    Inventor: Diana L. Parker
  • Patent number: 8568792
    Abstract: A mixed metal compound for pharmaceutical use is free from aluminium and has a phosphate binding capacity of at least 30%, by weight of the total weight of phosphate present, over a pH range of from 2-8. The compound is especially useful for treatment of hyperphosphataemia. The metals are preferably iron (III) and at least one of calcium, magnesium, lanthanum and cerium. A metal sulphate for pharmaceutical use is selected from at least one of calcium, lanthanum and cerium sulphate compounds and has a phosphate binding capacity of at least 30% by weight of the total phosphate present, over a pH range from 2-8.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: October 29, 2013
    Assignee: Cytochroma Development Inc.
    Inventors: Norman B Roberts, Maurice Webb, Benjamin J Rankin
  • Publication number: 20130243852
    Abstract: A composition and method for potentiating, sensitizing, and/or amplifying at least one HDAC inhibitor targeting at least one disease in a patient is provided. In one embodiment, the composition is administered to potentiate, sensitize and/or amplify an HDAC inhibitor targeting at least one cancer.
    Type: Application
    Filed: May 9, 2013
    Publication date: September 19, 2013
    Inventor: Robert Sabin
  • Publication number: 20130243885
    Abstract: The invention concerns a three component system comprising surface-active substances, vitamins and metal ions for efficient destruction and removal of contaminating proteins, nucleic acids and microorganisms from surfaces like for example laboratory benches, floors, equipment and instruments. These non-corrosive and non-toxic solutions for removal of proteins, nucleic acids and microorganisms are applied by spraying, rubbing or immersion of contaminated surfaces thereby destroying, solubilizing inactivating and removing proteins and nucleic acids. In that way also microorganisms are killed with high efficiency and at the same time all genetic information is inactivated.
    Type: Application
    Filed: April 21, 2013
    Publication date: September 19, 2013
    Applicant: MULTIBIND BIOTEC GMBH
    Inventors: Thomas Lisowsky, Karlheinz Esser, Richard Lisowsky
  • Publication number: 20130189375
    Abstract: Embodiments of the present disclosure include visible light antimicrobial materials comprising ?-Fe2O3 nanostructures fabricated by electron beam evaporation, methods of making the antimicrobial materials, and methods of using the antimicrobial materials.
    Type: Application
    Filed: January 23, 2013
    Publication date: July 25, 2013
    Applicant: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
    Inventor: UNIVERSITY OF GEORGIA RESEARCH FOUND
  • Publication number: 20130150652
    Abstract: A composition and method of arresting the flow of blood from a bleeding wound. The composition preferably includes an anhydrous salt ferrate compound preferably combined with an effective amount of an insoluble cation exchange material and an effective amount of anhydrous Magnetite mixed uniformly together. Povidone iodine may be added for enhanced antimicrobial properties. In the method, a quantity of the composition is magnetically attached to a surface of a magnet, after which the powderous mixture is applied to the wound by pressing the surface covered with the powderous compound against the wound for a time sufficient to clot the blood to arrest substantial further blood flow from the wound.
    Type: Application
    Filed: February 6, 2013
    Publication date: June 13, 2013
    Applicant: BIOLIFE, L.L.C.
    Inventor: BIOLIFE, L.L.C.
  • Publication number: 20130129810
    Abstract: In accordance with the present disclosure there are provided iron oxide nanoparticles for use in the treatment of non-infectious inflammatory disorders.
    Type: Application
    Filed: April 12, 2011
    Publication date: May 23, 2013
    Applicants: Tel Hashomer Medical Research Infrastructure and Services Ltd., RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Jonathan Leor, Tamar Ben-Mordechai, Shimrit Adutler-Lieber, Rimona Margalit, Inbar Elron-Gross, Yifat Glucksam-Galnoy
  • Publication number: 20130129787
    Abstract: Described herein is the synthesis of adhesive complex coacervates from electrostatically associated block copolymers, wherein the block copolymers comprise alternating polycationic and polyanionic blocks. Methods for making and the using the adhesive complex coacervates are also described herein.
    Type: Application
    Filed: February 25, 2011
    Publication date: May 23, 2013
    Inventor: Russell J. Stewart
  • Publication number: 20130121929
    Abstract: Iron oxide complexes, pharmacological compositions and unit dosage thereof, and methods for their administration, of the type employing an iron oxide complex with a polyol, are disclosed. The pharmacological compositions employ a polysaccharide iron oxide complex, wherein the polysaccharide is a modified polyol such as a carboxyalkylated reduced dextran. The complex is stable to terminal sterilization by autoclaving. The compositions are suitable for parenteral administration to a subject for the treatment of iron deficiencies or as MRI contrast agent. The complex is substantially immunosilent, provide minimal anaphylaxis and undergo minimal dissolution in vivo. The pharmacological compositions of the complex contain minimal free iron which can be quantified by a variety of methods.
    Type: Application
    Filed: January 4, 2013
    Publication date: May 16, 2013
    Applicant: AMAG Pharmaceuticals, Inc.
    Inventor: AMAG Pharmaceuticals, Inc.
  • Patent number: 8425945
    Abstract: The present invention relates to methods for promoting dispersal of, or preventing formation of microbial biofilms, comprising: exposing a biofilm to an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent; treating a surface or medium susceptible to biofilm formation with an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent; incorporating an effective amount of nitric oxide or at least one nitric oxide generating or releasing agent in a surface or medium susceptible to biofilm formation; or inducing the accumulation of one or more reactive oxygen or nitrogen species within microorganisms within said biofilm or capable of forming a biofilm. The invention also relates to methods for maintaining or enhancing or maintaining and enhancing the functioning of a biofilm, comprising exposing a biofilm to at least one nitric oxide scavenger, at least one antioxidant or at least one nitric oxide scavenger and at least one antioxidant.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: April 23, 2013
    Assignee: NewSouth Innovations Pty Limited
    Inventors: Nicolas Louis Gabriel Barraud, Jeremy Stephen Webb, Scott Alan Rice
  • Patent number: 8377482
    Abstract: The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: February 19, 2013
    Assignee: Warburton Technology Limited
    Inventors: Robert N. Laurie, William A. Smith
  • Publication number: 20130039984
    Abstract: The present invention relates to a new manufacture process for producing an iron containing phosphate adsorbent, in particular to a process for manufacturing and isolating an iron(III)-based phosphate adsorbent which exhibits valuable pharmacological properties.
    Type: Application
    Filed: October 17, 2012
    Publication date: February 14, 2013
    Applicant: Novartis AG
    Inventor: Novartis AG
  • Patent number: 8361504
    Abstract: The subject invention pertains to materials and methods for stopping or decreasing the blood flow from an open wound or medical or surgical procedure. Compositions of the invention comprise a salt form of a cross-linked polyacrylic acid. In one embodiment, the composition comprises a sodium salt of a polyacrylic acid. Compositions of the invention can also optionally comprise one or more different salt ferrates, and/or a cationic exchanger resins, and/or a silver compound. In an exemplified embodiment, a composition of the invention comprises sodium polyacrylate provided in a dry powdered form. Polyacrylate compositions of the invention can be applied directly to a wound or treatment site, or they can be incorporated into a wound dressing, such as a bandage. The clot or scab formed at a wound or treatment site treated with the present invention is extremely elastic and exhibits considerable tensile strength when stretched to the breaking point.
    Type: Grant
    Filed: April 9, 2009
    Date of Patent: January 29, 2013
    Assignee: Biolife, LLC
    Inventors: John Hen, John Alfred Thompson, Talmadge Kelly Keene, Michael H. Tollon, Mark Travi, Roger Thomas